Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07217470 · ClinicalTrials.gov registry record
Fluid Status of ESRD Patients Undergoing Dialysis
A clinical trial, sponsored by HemoCept.
- Completed
- Registry status
- 26
- Enrollment target
NCT07217470: Completed study, sponsored by HemoCept.
NCT07217470 is a clinical trial that has completed, run by HemoCept. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07217470 has completed, sponsored by HemoCept.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
The pilot clinical study will assess the correlation between fluid removal during dialysis and HemoCept device data.
Primary Outcome
The primary analysis will be conducted using HemoCept device readings taken before dialysis and at the end of dialysis, just prior to return of blood and fluid from the machine. The device data will then be assessed for its comparison to dry weight changes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2025-08-18 |
| Est. Completion | 2025-11-20 |
What the finished NCT07217470 record still lists
NCT07217470 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT07217470 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07217470 about?
NCT07217470 is a clinical study titled "Fluid Status of ESRD Patients Undergoing Dialysis". The pilot clinical study will assess the correlation between fluid removal during dialysis and HemoCept device data.
What is the current status of trial NCT07217470?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2025-08-18. Estimated completion is 2025-11-20.
Who is sponsoring clinical trial NCT07217470?
This trial is sponsored by HemoCept, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI